Marketing and Communications Coordinator
Recce Pharmaceuticals LtdSydneyCBD, Inner West & Eastern SuburbsMarketing & CommunicationsMarketing Assistants/CoordinatorsFull TimePosted 12d agoSave jobMarketing and Communications Coordinator
The Opportunity
This exciting full-time role will see you responsible for marketing and communications support for Recce Pharmaceuticals, an ASX and FSE listed Australian Biotech CompanyAs a Marketing and Communications Coordinator, you will work collaboratively with the team to support business priorities, drive projects and events, and produce multi-channel marketing and communication assets that align with Recce’s objectives. You will have the opportunity to work for an innovative publicly listed biotechnology company. This role will present you with the chance to use your skills and knowledge to contribute to the marketing function of the business as well as grow within the wider team.
Your responsibilities will include…
- Working closely with the Sydney team to plan and implement marketing and communications strategy.
- Integrate key messaging amongst various regions and markets to ensure consistency.
- Prepare high-quality written content for various channels including ASX announcements and biotech/life sciences articles.
- Assisting in the creation and editing of marketing materials
- Coordinate media opportunities and investor events/conferences.
- Assisting with company communications; including annual report, quarterly website, and messaging review.
We are looking for someone who has..
- Experience in a marketing and/or communications role
- Experience writing articles for external publication
- Excellent verbal and written communication skills
- Exceptional attention to detail
- Ability to work well under pressure, intelligent and proactive
- Relevant tertiary qualifications in Communications, Marketing or Business
- Experience in biotech/life sciences or publicly listed company highly regarded
About Recce PharmaceuticalsRecce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) is pioneering the development and commercialisation of a New Class of Synthetic Anti-Infectives designed to address the urgent global health threat posed by antibiotic resistant superbugs and emerging viral pathogens.
Recce’s anti-infectives have been designed with a unique mechanism of action, with the goal of re-empowering physicians with an effective treatment that may be used repeatedly against a broad range of bacteria and viruses.
If you feel that you have the skills and experience to be successful in this role, please apply today!Australian Citizenship Required. Sydney Location
Applications close 14 July 2021
- Forums
- ASX - By Stock
- RCE
- RCE Media
RCE Media, page-371
Featured News
Add RCE (ASX) to my watchlist
(20min delay)
|
|||||
Last
56.0¢ |
Change
-0.035(5.88%) |
Mkt cap ! $116.2M |
Open | High | Low | Value | Volume |
59.5¢ | 59.5¢ | 56.0¢ | $156.3K | 273.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 29113 | 56.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
59.0¢ | 587 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 29113 | 0.560 |
3 | 27975 | 0.550 |
2 | 51000 | 0.540 |
2 | 52000 | 0.530 |
1 | 50000 | 0.525 |
Price($) | Vol. | No. |
---|---|---|
0.590 | 587 | 1 |
0.595 | 51883 | 2 |
0.600 | 209104 | 3 |
0.605 | 2000 | 1 |
0.610 | 20000 | 1 |
Last trade - 16.10pm 05/06/2024 (20 minute delay) ? |
|
|||||
Last
57.0¢ |
  |
Change
-0.035 ( 2.56 %) |
|||
Open | High | Low | Volume | ||
58.0¢ | 58.0¢ | 56.0¢ | 61716 | ||
Last updated 15.34pm 05/06/2024 ? |
Featured News
RCE (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non-Executive Director
Simon Kidston
Non-Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online